CytomX Therapeutics, Inc. Public Float
CytomX Therapeutics, Inc. (CTMX) had Public Float of $372.30 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $372.30M.
- 2024-06-28: Entity Public Float $94.40M.
- 2023-06-30: Entity Public Float $114.10M.
- 2022-06-30: Entity Public Float $118.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $372.30M 10-K · filed 2026-03-16 |
| 2024-06-28 | $94.40M 10-K · filed 2025-03-06 |
| 2023-06-30 | $114.10M 10-K · filed 2024-03-11 |
| 2022-06-30 | $118.40M 10-K · filed 2023-03-27 |
| 2021-06-30 | $408.30M 10-K/A · filed 2023-03-27 |
| 2020-06-30 | $379.40M 10-K · filed 2021-02-24 |
| 2019-06-28 | $501.80M 10-K · filed 2020-02-27 |
| 2018-06-30 | $876.40M 10-K · filed 2019-02-27 |
| 2017-06-30 | $360.50M 10-K · filed 2018-03-07 |
| 2016-06-30 | $197.30M 10-K · filed 2017-03-02 |
| 2015-06-30 | $0.00 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |